Uploaded October 2026 | Updated November 2026, 1 day ago
When should men start thinking about a PSA test—and why can timing matter in prostate cancer? In this Stories from the Barbershop conversation, Erik shares insights from 25 years of lived experience, including why “you are not your cancer” and why quality of life should remain central to care.
Erik, who was diagnosed in Belgium with high-risk but localized prostate cancer, discusses how early detection may help identify cancer before it becomes metastatic. He also shares his patient advocacy work with the European Prostate Cancer Coalition (Europa Uomo) and what he would like to see change in prostate cancer care.
In this episode:
- What “quality of life” can mean after diagnosis and treatment
- PSA (prostate-specific antigen): what it is and how it may be used in assessing risk
- When a first PSA test is often discussed (around ages 45–50)
- Risk factors discussed: family history and race
- Why awareness, screening, and early diagnosis are key focus areas
Part of Bayer’s Stories from the Barbershop series with barber and mental health advocate Tom Chapman.
This video is for informational purposes only and does not provide medical advice. Talk to a healthcare professional about screening, diagnosis, or treatment decisions.
#LifeBeyondProstateCancer #HealthForAll #HungerForNone
When should men start thinking about a PSA test—and why can timing matter in prostate cancer? In this Stories from the Barbershop conversation, Erik shares insights from 25 years of lived experience, including why “you are not your cancer” and why quality of life should remain central to care.
Erik, who was diagnosed in Belgium with high-risk but localized prostate cancer, discusses how early detection may help identify cancer before it becomes metastatic. He also shares his patient advocacy work with the European Prostate Cancer Coalition (Europa Uomo) and what he would like to see change in prostate cancer care.
In this episode:
- What “quality of life” can mean after diagnosis and treatment
- PSA (prostate-specific antigen): what it is and how it may be used in assessing risk
- When a first PSA test is often discussed (around ages 45–50)
- Risk factors discussed: family history and race
- Why awareness, screening, and early diagnosis are key focus areas
Part of Bayer’s Stories from the Barbershop series with barber and mental health advocate Tom Chapman.
This video is for informational purposes only and does not provide medical advice. Talk to a healthcare professional about screening, diagnosis, or treatment decisions.
#LifeBeyondProstateCancer #HealthForAll #HungerForNone










